Afatinib
The serum concentration of Afatinib can be increased when it is combined with Naltrexone.
Alfentanil
The therapeutic efficacy of Alfentanil can be decreased when used in combination with Naltrexone.
Alphaprodine
The therapeutic efficacy of Alphaprodine can be decreased when used in combination with Naltrexone.
Advertisement
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Naltrexone.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Naltrexone.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Naltrexone.
Advertisement
Buprenorphine
The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone.
Butorphanol
The therapeutic efficacy of Butorphanol can be decreased when used in combination with Naltrexone.
Codeine
The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.
Advertisement
Codeine Anhydrous
The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.
CODEINE POLISTIREX
The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Naltrexone.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Naltrexone.
Dextromoramide
The therapeutic efficacy of Dextromoramide can be decreased when used in combination with Naltrexone.
Dezocine
The therapeutic efficacy of Dezocine can be decreased when used in combination with Naltrexone.
Dihydrocodeine
The therapeutic efficacy of Dihydrocodeine can be decreased when used in combination with Naltrexone.
Diphenoxylate
The therapeutic efficacy of Diphenoxylate can be decreased when used in combination with Naltrexone.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Naltrexone.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Naltrexone.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Naltrexone.
Ethylmorphine
The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with Naltrexone.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Naltrexone.
Fentanyl
The therapeutic efficacy of Fentanyl can be decreased when used in combination with Naltrexone.
Heroin
The therapeutic efficacy of Heroin can be decreased when used in combination with Naltrexone.
Hydrocodone
The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Naltrexone.
HYDROCODONE POLISTIREX
The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Naltrexone.
Hydromorphone
The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Naltrexone.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Naltrexone.
Levomethadyl
The therapeutic efficacy of Levomethadyl Acetate can be decreased when used in combination with Naltrexone.
Levorphanol
The therapeutic efficacy of Levorphanol can be decreased when used in combination with Naltrexone.
Meperidine
The therapeutic efficacy of Pethidine can be decreased when used in combination with Naltrexone.
Methadone
The therapeutic efficacy of Methadone can be decreased when used in combination with Naltrexone.
Methadyl Acetate
The therapeutic efficacy of Methadyl Acetate can be decreased when used in combination with Naltrexone.
Methylnaltrexone
The risk or severity of adverse effects can be increased when Naltrexone is combined with Methylnaltrexone.
Morphine
The therapeutic efficacy of Morphine can be decreased when used in combination with Naltrexone.
Nalbuphine
The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Naltrexone.
Naloxegol
The risk or severity of adverse effects can be increased when Naltrexone is combined with Naloxegol.
Normethadone
The therapeutic efficacy of Normethadone can be decreased when used in combination with Naltrexone.
Opium
The therapeutic efficacy of Opium can be decreased when used in combination with Naltrexone.
Oxycodone
The therapeutic efficacy of Oxycodone can be decreased when used in combination with Naltrexone.
Oxymorphone
The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Naltrexone.
Paregoric
The therapeutic efficacy of Morphine can be decreased when used in combination with Naltrexone.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Naltrexone.
Pentazocine
The therapeutic efficacy of Pentazocine can be decreased when used in combination with Naltrexone.
Pirinitramide
The therapeutic efficacy of Piritramide can be decreased when used in combination with Naltrexone.
Propoxyphene
The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Naltrexone.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Naltrexone.
Remifentanil
The therapeutic efficacy of Remifentanil can be decreased when used in combination with Naltrexone.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Naltrexone.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Naltrexone.
Sufentanil
The therapeutic efficacy of Sufentanil can be decreased when used in combination with Naltrexone.
Tapentadol
The therapeutic efficacy of Tapentadol can be decreased when used in combination with Naltrexone.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Naltrexone.
Tramadol
The therapeutic efficacy of Tramadol can be decreased when used in combination with Naltrexone.
Vincristine
The excretion of Vincristine can be decreased when combined with Naltrexone.
